secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001453687-26-000068
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cartesian Therapeutics board member Murat Kalayoglu resigns effective March 31, 2026
--------------------------------------------------------------------------------

- Director Murat Kalayoglu, M.D., Ph.D. resigned from board effective March 31, 2026 to pursue other opportunities.
- He served as Chairman of Science and Technology Committee and on Nominating and Corporate Governance Committee.
- Resignation not due to any disagreement with the company on operations, policies, or practices.
- Kalayoglu had been on board since 2023; no replacement announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368726000068/0001453687-26-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368726000068/rnac-20260326.htm
  HTML page:      https://secwatch.observer/filing/0001453687-26-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer